# K041838: MPS (or MPS-T)

- Pathway: 510(k) (Traditional)
- Applicant: Innerspace, Inc.
- Decided: Mar 1, 2005 after 237 days
- Product code: GWM (Device, Monitoring, Intracranial Pressure)
- Device class: 2
- Regulation: 21 CFR 882.1620
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 2 generations back to K002765 (2000). 4 ancestors in all.
3 later devices descend from it; 1 cites it directly.
0 of 8 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K013005: Act 11 MP Ventricular Catheter, Innerspace, Inc. (2002) Summary page 1.
- K013705: Act Iii Ventricular Catheter, Innerspace, Inc. (2002) Summary page 1.
- K002765: Licox CMP Monitor-AC3.1, Licox Imc Oxygen Catheters-CC1,CC1.SB Luicox Imc Introducer Kits-IM,IM2,IM3,II1 Licoximc Tempe, Integra Neurosciences (2000) Summary page 1.

## Most influential descendants
- K072379: MPS Oxiport and MPS Oxiport Plus (2008), 2 descendants of its own
- K083378: Synergy (2009), 1 descendant of its own
- K161010: HICP200 Patient/Monitor Interconnect Cable (2016), 0 descendants of its own

## Indications for use
The use of MPS (or MPS-T) by a qualified neurosurgeon is indicated when direct measurement of intracranial pressure is clinically important, when the patient may require CSF drainage in the course of their care and when data from a second or third parameter may be deemed useful in optimum patient management.

Source page: https://510kreport.com/device/K041838
Methodology: https://510kreport.com/methodology